# FDA Inspection 1253473 - Octapharma Plasma, Inc. - October 24, 2024

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/246b0f9a-d9d6-42f1-b367-e2ec39b34ecf
Source feed: FDA_Inspections

> FDA Inspection 1253473 for Octapharma Plasma, Inc. on October 24, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253473
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2024-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253473 - 2024-10-24](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6df6bd76-9e72-4e85-8f0d-4cb1d45528d2)
- [FDA Inspection 1049124 - 2018-04-04](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/9cb9d735-5566-43fc-9f93-9cdbcce1d244)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/c1a5aac5-342d-4edb-815d-a3fcfb9cf744

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d